<img src="https://ml.globenewswire.com/Resource/Download/a1e3887d-3378-46c5-938d-2b0d5a7c825f?size=2" nborder="0" align="left" hspace="5" vspace="5" title="NeurAxis Logo.png" alt="NeurAxis, Inc."/>CARMEL, Ind., Sept. 16, 2026 <a href="https://www.globenewswire.com" target="_blank">(GLOBE NEWSWIRE)</a> -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29-30, 2026. Company Webcast The webcast presentation will take place at 11:45 a.m. ET on Tuesday, September 29, 2026. The webcast can be accessed by visiting the conference website at <a href="https://www.globenewswire.com/Tracker?data=G9mNlCkJONiCw8F8rHTyslX2pk_IELzvfhdExbkqo2HCfZbDd_ZuHmKsRZ88Hcm3bypDgDpvpGJEyCuT52ybE4aeD81ODLzfrp4UgW9ZqTfTPBgzzSMxM7WAhdYPFoxdDv5n6O7LXgqVZEUoCcgbVA==" rel="nofollow" target="_blank" title="">https://lythampartners.com/fall2026/</a> or directly at <a href="https://www.globenewswire.com/Tracker?data=G9mNlCkJONiCw8F8rHTysvHpTW2-pLfWhm7sjkzI3Ur4xD8zg805KKl5lqZ4AO7re6GlnMOCYP4SSfihpevcCt7BrSJ7Z175EBSU5UUIZCvFdBukp1mQJjUMFKqo1wE86IAn7f3Ovu8iT-x5pF2aRw==" rel="nofollow" target="_blank" title="">https://app.webinar.net/lJ5aBmzWwkZ</a>. The webcast will also be available for replay following the event. 1x1 Meetings Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at <a href="https://www.globenewswire.com/Tracker?data=tQKFrMJS4167DrlTEdCgWOLw108fXOe4wzwyi_g35JF5snrXO9nthk-j1HrRyx_lrJWbEcWAnB_xRPhr3ufVFOjSIAd1CZpnSHMzA1WQK3k=" rel="nofollow" target="_blank" title="1x1@lythampartners.com">1x1@lythampartners.com</a> or register for the event at <a href="https://www.globenewswire.com/Tracker?data=G9mNlCkJONiCw8F8rHTyslX2pk_IELzvfhdExbkqo2FG1jMB7CRCuXIP_5RseUEJRTASxxqSXKCGjysAoiloL402fYpi27sKzFwjRXRaXHgiZVjnqAAbx05sHOEL2oofaBNdNJ3h7RfGQ8ff-SPibA==" rel="nofollow" target="_blank" title="">https://lythampartners.com/fall2026invreg/</a>.    About NeurAxis, Inc. NeurAxis, Inc., is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. NeurAxis is dedicated to advancing science and leveraging evidence-based medicine to drive the adoption of IB-Stim, its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, by the medical, scientific, and patient communities. IB-Stim is FDA-cleared for functional abdominal pain in irritable bowel syndrome (IBS) and functional dyspepsia, including FD-linked nausea symptoms in patients ages 8 and older. Additional clinical trials of PENFS in multiple pediatric and adult conditions with large unmet healthcare needs are underway. For more information, please visit <a href="https://www.globenewswire.com/Tracker?data=jLm0kOZUWv24rO4MOG4a7mFtRJ3v-hwRzKM1Knavrd_pIeVGBn4N-jeACPnBx_207MOeC9T6OvNT562uInWGhixFGNly3-GMvBociFzYJL88ucDgMampCJeiXUlmakcNLIVM12cyB22PYDJiulk79c8XLLSe8dMzCSp_i-rMmEn767IP47nMif2yTGPylQlJKLJ02-xzfJIxTzJQ31AGpHZ9WVsoN7GwmeJw45WwXZCKC16IX2oVbaCJ6dhol_UVq-QT0KyVJQ6sbVIJ3nh-aA==" rel="nofollow" target="_blank" title="">http://neuraxis.com</a>. Contacts: Company NeurAxis, Inc. <a href="https://www.globenewswire.com/Tracker?data=q3CjJipMC_oayG5NSNdzeo0TSlFmuXBKFwFKzMqXeQ-KGWrMBqz8f6i4K2scPvgAMfsHArNR1XnLY4nY_p-B6vArsaNXQ_YmzxR3-OL6S_w=" rel="nofollow" target="_blank" title="info@neuraxis.com">info@neuraxis.com</a> Investor Relations Lytham Partners Ben Shamsian 646-829-9701 <a href="https://www.globenewswire.com/Tracker?data=_C7ht0O_uixeOSX-5pXwcBJxJD-99JCBgXWA9MWkVuFtaa4SRgE6VGTkTe2Gf6R8kyJFAoMyBCZUQJX6iB-jmQsxMOG6GSmJGMI07ivZcIF-BX8FP3Y9iJZ7P4YyHZ8ukTReBfmIZlPClIKhlV-OSbMXqcVMeqs03DLRFd9JbDgpPjvRsOZBHG2OSlaI6fbez2LXOzdnyidIbYiUaehXdL6ldy77siAMI1tUelucWpWtTpt_jP_gDY9T_U9MMcBub4u3IeoqukjkM9j3wbT_3Aq2QTlns-8gWt21xdgeROPuKLlqgN94KuTY8yfg-b9G" rel="nofollow" target="_blank" title="shamsian@lythampartners.com">shamsian@lythampartners.com</a> <img alt="" src='https://ml.globenewswire.com/media/NTIxZjQxNjEtYjFiYS00MTUxLWFmZTctY2UwNjA4MzY0MGNlLTEyNjM3OTUtMjAyNi0wOS0xNi1lbg==/tiny/NeurAxis-Inc-.png' referrerpolicy='no-referrer-when-downgrade' />

NeurAxis to Participate in the Lytham Partners Fall 2026 Investor Conference

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn